Humana Forecast, price target & analysts
Humana Target price 2025 - Analyst rating & recommendation
Humana Classifications & Recommendation:
Humana Price Target
| Target Price | $298.82 |
| Price | $256.69 |
| Potential |
16.41%
register free of charge
|
| Number of Estimates | 22 |
|
22 Analysts have issued a price target Humana 2026 .
The average Humana target price is $298.82.
This is
16.41%
register free of charge
$348.00
35.57%
register free of charge
$256.00
0.27%
register free of charge
|
|
| A rating was issued by 27 analysts: 9 Analysts recommend Humana to buy, 18 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Humana stock has an average upside potential 2026 of
16.41%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 117.81 | 126.52 |
| 10.68% | 7.39% | |
| Net Margin | 1.02% | 1.49% |
| 54.87% | 45.59% |
20 Analysts have issued a sales forecast Humana 2025 . The average Humana sales estimate is
This results in the following potential growth metrics:
17 Humana Analysts have issued a net profit forecast 2025. The average Humana net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 9.99 | 15.59 |
| 50.05% | 56.06% | |
| P/E | 16.46 | |
| EV/Sales | 0.32 |
17 Analysts have issued a Humana forecast for earnings per share. The average Humana EPS is
This results in the following potential growth metrics and future valuations:
Current Humana Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Oppenheimer |
Locked
➜
Locked
|
Locked | May 01 2025 |
| Cantor Fitzgerald |
Locked
➜
Locked
|
Locked | May 01 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Apr 15 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Mizuho |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Oppenheimer:
Locked
➜
Locked
|
May 01 2025 |
|
Locked
Cantor Fitzgerald:
Locked
➜
Locked
|
May 01 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Apr 15 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Apr 09 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
